Mustang Bio rises after FDA orphan drug status for MB-101
Source: SeekingAlpha
2025-07-07 09:17:07 ET
More on Mustang Bio
Read the full article on Seeking Alpha
For further details see:
Mustang Bio rises after FDA orphan drug status for MB-101
Mustang Bio Inc.
NASDAQ: MBIO
MBIO Trading
5.58% G/L:
$0.95 Last:
32,335 Volume:
$0.92 Open:
MBIO Latest News
MBIO Stock Data
$6,149,480
6,934,132
3.57%
16
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
